Bleomycin‐induced fibrosis in MC1 signalling‐deficient C57BL/6J‐Mc1re/e mice further supports a modulating role for melanocortins in collagen synthesis of the skin

The melanocortin‐1 receptor (MC₁) binds α‐melanocyte‐stimulating hormone (α‐MSH) with high affinity and has a physiological role in cutaneous melanin pigmentation. Previously, we reported that human dermal fibroblasts also express functional MC₁. α‐MSH suppressed transforming growth factor‐β₁‐ and bleomycin (BLM)‐induced collagen synthesis in vitro and in vivo. Using MC₁ signalling‐deficient C57BL/6J‐Mc1r^e/e mice, we tested as to whether MC₁ has a regulatory role on dermal collagen synthesis in the BLM model of scleroderma. Notably, mice with a C57BL/6J genetic background were previously shown to be BLM‐non‐susceptible. Interestingly, treatment of C57BL/6J‐Mc1r^e/e but not of C57BL/6J‐wild‐type mice with BLM increased cutaneous collagen type I content at RNA and protein level along with development of skin fibrosis. Cutaneous levels of connective tissue growth factor and monocyte chemotactic protein‐1 were also increased in BLM‐treated C57BL/6J‐Mc1r^e/e mice. Primary dermal fibroblasts from C57BL/6J‐wt mice further expressed MC₁, suggesting that these cells are directly targeted by melanocortins to affect collagen production of the skin. Our findings support the concept that MC₁ has an endogenous regulatory function in collagen synthesis and controls the extent of fibrotic stress responses of the skin.